Does minimally invasive fibroid removal change whether fallopian tubes are open?

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center interventional study uses chromopertubation during laparoscopic or robotic uterine-preserving myomectomy to document tubal patency before and after fibroid removal. A dilute methylene blue solution is introduced into the uterus during surgery to see whether dye spills from the fallopian tubes, with the minimum dye dose used to reduce risk. Patients with prior tubal surgery, known tubal occlusion, absent tubes, pregnancy, methylene blue allergy, or G6PD deficiency are excluded. The goal is to clarify whether fibroids or their surgical removal affect tubal openness and thus could influence fertility counseling and management.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients undergoing minimally invasive laparoscopic or robotic-assisted uterine-preserving gynecologic surgery for removal of uterine fibroids (myomectomy) by a minimally invasive gynecologic surgeon at MedStar.

Exclusion Criteria:

* Patients with both fallopian tubes absent
* Patients in whom it is not possible to place a uterine manipulator or catheter
* Patient with known tubal disease or occlusion, or patients who have undergone prior tubal surgery
* Patients with allergy to methylene blue dye or G6PD deficiency
* Patients with positive pregnancy test on day of surgery

Where it's running

• MedStar Washington Hospital Center
  Washington D.C., District of Columbia, United States Recruiting

Study contacts

• Study coordinator: Alexandra Snyder, MD
• Email: alexandra.snyder@medstar.net
• Phone: 202-877-6526

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Spraying low‑concentration lidocaine under the diaphragm to reduce shoulder pain after single‑port gynecologic laparoscopy

  This will try spraying 0.08% lidocaine under the diaphragm at the start of single‑port laparoscopic surgery to see if it reduces immediate postoperative shoulder pain and improves mood for women having benign gynecologic operations.

  Recruiting Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT07537127

• Preventing bleeding during myomectomy with misoprostol

  This will test whether giving misoprostol before myomectomy reduces surgical bleeding in women aged 18–43 having surgery for symptomatic uterine fibroids.

  Recruiting University Hospital, Clermont-Ferrand · Clermont-Ferrand, Clermont-Ferrand · NCT06882824

• Rotating hinge vs condylar constrained knee implants in revision knee replacement

  This study tests whether rotating hinge knee implants perform similarly to condylar constrained implants when used to revise knee replacements in adults.

  Recruiting at 2 sites Medstar Health Research Institute · Washington D.C., District of Columbia and 1 other locations · NCT07818343

• Patient and caregiver perspectives on bladder instillations for urinary symptoms

  This project talks with adults who have neurogenic bladder and their caregivers to see what they prefer and experience with bladder instillations of Lactobacillus, gentamicin, or both.

  Recruiting Medstar Health Research Institute · Washington D.C., District of Columbia · NCT07390591

• Collared versus collarless femoral stems for primary total hip replacement

  This trial will test whether adding a collar to a femoral stem reduces sinking (subsidence) and lowers fracture risk in adults having an uncemented total hip replacement for osteoarthritis.

  Recruiting Medstar Health Research Institute · Washington D.C., District of Columbia · NCT07337642

• Virtual reality cognitive behavioral therapy for chronic cancer pain

  This project tests whether a virtual reality program that delivers cognitive behavioral therapy can help adults with chronic cancer pain feel less pain than a two-dimensional tablet program.

  Recruiting at 2 sites Medstar Health Research Institute · Washington D.C., District of Columbia and 1 other locations · NCT07318519

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.